Change of public accounting firm
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your RENX notes
LONDON and NEW YORK, 25 June 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces the appointment of CohnReznick LLP as the Company's US independent registered public accounting firm for the fiscal year ended June 30, 2024.
On June 21, 2024, Ernst & Young LLP, was informed of their dismissal as the Company's independent registered public accounting firm with such dismissal to be effective as of June 18, 2024.
James McCullough, CEO of Renalytix plc, commented: "We will continue to look for opportunities to improve cost efficiencies and grow revenue as they become available. We are reducing administrative expenses to allocate more resources into sales and marketing, which is proving effective."
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.